Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice

[Display omitted] Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Long noncoding RNAs (lncRNAs) wra...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 200; p. 115032
Main Authors Li, Liangyun, Bi, Yihui, Diao, Shaoxi, Li, Xiaofeng, Yuan, Tong, Xu, Tao, Huang, Cheng, Li, Jun
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.06.2022
Subjects
Exosomes
Hepatocellular carcinoma
LncRNAs
Therapy
Therapy
ceRNA
NAFLD
lncRNA
Hepatocellular carcinoma
mRNA
Exosomes
ncRNAs
ctDNA
TAMs
MREs
RNA SEQ
miRNA
HBV
CTCs
LncRNAs
qRT-PCR
HCC
EMT
TME
IL-6
PPIs
IPSCs
LC
HCV
HSCs
CHB
HUVECs
Online AccessGet full text
ISSN0006-2952
1873-2968
1873-2968
DOI10.1016/j.bcp.2022.115032

Cover

Abstract [Display omitted] Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Long noncoding RNAs (lncRNAs) wrapped in exosomes can change the expression of their target genes in recipient cells, thereby regulating the behavior of recipient cells. Increasing evidence has demonstrated that there is a correlation between the activation of exosomal lncRNAs and the development of HCC. In this review article, we highlighted the functions of exosomal lncRNAs in the development of HCC, showing that exosomal lncRNAs play a vital role in the growth and progression of HCC and are targets for HCC.
AbstractList Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Long noncoding RNAs (lncRNAs) wrapped in exosomes can change the expression of their target genes in recipient cells, thereby regulating the behavior of recipient cells. Increasing evidence has demonstrated that there is a correlation between the activation of exosomal lncRNAs and the development of HCC. In this review article, we highlighted the functions of exosomal lncRNAs in the development of HCC, showing that exosomal lncRNAs play a vital role in the growth and progression of HCC and are targets for HCC.Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Long noncoding RNAs (lncRNAs) wrapped in exosomes can change the expression of their target genes in recipient cells, thereby regulating the behavior of recipient cells. Increasing evidence has demonstrated that there is a correlation between the activation of exosomal lncRNAs and the development of HCC. In this review article, we highlighted the functions of exosomal lncRNAs in the development of HCC, showing that exosomal lncRNAs play a vital role in the growth and progression of HCC and are targets for HCC.
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Long noncoding RNAs (lncRNAs) wrapped in exosomes can change the expression of their target genes in recipient cells, thereby regulating the behavior of recipient cells. Increasing evidence has demonstrated that there is a correlation between the activation of exosomal lncRNAs and the development of HCC. In this review article, we highlighted the functions of exosomal lncRNAs in the development of HCC, showing that exosomal lncRNAs play a vital role in the growth and progression of HCC and are targets for HCC.
[Display omitted] Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Long noncoding RNAs (lncRNAs) wrapped in exosomes can change the expression of their target genes in recipient cells, thereby regulating the behavior of recipient cells. Increasing evidence has demonstrated that there is a correlation between the activation of exosomal lncRNAs and the development of HCC. In this review article, we highlighted the functions of exosomal lncRNAs in the development of HCC, showing that exosomal lncRNAs play a vital role in the growth and progression of HCC and are targets for HCC.
ArticleNumber 115032
Author Li, Jun
Li, Liangyun
Bi, Yihui
Xu, Tao
Li, Xiaofeng
Huang, Cheng
Diao, Shaoxi
Yuan, Tong
Author_xml – sequence: 1
  givenname: Liangyun
  surname: Li
  fullname: Li, Liangyun
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
– sequence: 2
  givenname: Yihui
  surname: Bi
  fullname: Bi, Yihui
  organization: The Second Affiliated Hospital of Anhui Medical University, China
– sequence: 3
  givenname: Shaoxi
  surname: Diao
  fullname: Diao, Shaoxi
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
– sequence: 4
  givenname: Xiaofeng
  surname: Li
  fullname: Li, Xiaofeng
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
– sequence: 5
  givenname: Tong
  surname: Yuan
  fullname: Yuan, Tong
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
– sequence: 6
  givenname: Tao
  surname: Xu
  fullname: Xu, Tao
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
– sequence: 7
  givenname: Cheng
  surname: Huang
  fullname: Huang, Cheng
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
– sequence: 8
  givenname: Jun
  surname: Li
  fullname: Li, Jun
  email: lj@ahmu.edu.cn
  organization: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35395241$$D View this record in MEDLINE/PubMed
BookMark eNp9kE9P4zAQxa0Vq6Xt7gfYC_KRS4vtJI4DJ1TxT6oWCYH2aDmTqXCV2MF2EXx7XLVcOHDyjOe9p6fflBw575CQv5wtOOPybLNoYVwIJsSC84oV4geZcFUXc9FIdUQmjDGZ50ock2mMm92qJP9FjouqyL8ln5D_V28--sH0dOXg4d9lpMZ19BlHkzxg3297E-jSBLAuq87pdfADbU20QANGzIdnmjyF3joLOWUMBpIF_E1-rk0f8c_hnZGn66vH5e18dX9zt7xczSF3SPNa1U0nW1Vx1lQSSqiBMSxKXIvc1VSdYo0oIV-NUnlmsmzyakzBOZOtLGbkdJ87Bv-yxZj0YOOuuHHot1ELWSrVlI1gWXpykG7bATs9BjuY8K4_YWRBvRdA8DEGXGuwySTrXQrG9pozvcOuNzpj1zvseo89O_kX52f4d56LvQcznleLQUew6AA7GxCS7rz9xv0Bg9yXmg
CitedBy_id crossref_primary_10_1002_wrna_1808
crossref_primary_10_3389_fimmu_2023_1127214
crossref_primary_10_3389_fonc_2022_1014949
crossref_primary_10_3390_pharmaceutics15092365
crossref_primary_10_1007_s12094_022_02904_w
crossref_primary_10_3390_cancers15030959
Cites_doi 10.1016/j.prp.2019.152468
10.1002/jcb.29363
10.21037/jgo.2016.09.07
10.1016/j.ymthe.2019.09.001
10.18632/oncotarget.9883
10.1016/j.mam.2018.09.002
10.1080/17425255.2021.1887139
10.21873/cgp.20266
10.1186/s12943-018-0843-8
10.18632/oncotarget.16684
10.1038/s41572-018-0014-7
10.3748/wjg.v26.i2.109
10.3390/ijms19102958
10.1007/s12072-019-09988-7
10.1002/jcb.27109
10.1016/j.ncrna.2016.06.001
10.2147/OTT.S284167
10.1016/j.toxlet.2019.09.008
10.3390/ncrna4040040
10.1177/1947601913499020
10.1007/s00018-017-2595-9
10.5582/ddt.2019.01009
10.1016/j.ejphar.2019.172787
10.1152/ajpgi.00242.2017
10.1016/j.canlet.2018.01.008
10.1002/biot.201600699
10.1007/s11427-013-4553-6
10.1177/1533033821990060
10.1007/978-981-10-5765-6_2
10.1186/s12943-015-0426-x
10.1002/cam4.3313
10.1093/jnci/djn341
10.1093/abbs/gmx017
10.1111/cpr.12795
10.1089/gtmb.2018.0237
10.1016/j.bbagrm.2019.194419
10.1002/hep.27406
10.1158/1055-9965.EPI-17-0770
10.1016/j.gpb.2015.02.001
10.3233/CBM-170727
10.1002/advs.201801313
10.1016/j.lfs.2018.02.006
10.1016/j.devcel.2019.04.011
10.1097/CEJ.0000000000000571
10.3390/ijms17122028
10.3389/fcvm.2022.791156
10.1158/1541-7786.MCR-13-0636
10.1016/j.ccr.2014.07.009
10.1111/os.12690
10.1038/s41551-019-0485-1
10.1002/jcb.28757
10.18632/aging.202430
10.3748/wjg.v25.i35.5283
10.1002/ijc.31931
10.1038/onc.2017.184
10.1038/ng.710
10.1016/S0140-6736(18)30010-2
10.1007/s12265-018-9796-y
10.1002/hep.30662
10.1016/j.cca.2015.02.046
10.3390/ijms20061406
10.1053/j.gastro.2006.08.026
10.3390/cells9010190
10.1016/j.gene.2019.144044
10.1155/2022/9631036
10.3724/abbs.2021019
10.1002/iub.2141
10.1111/cas.14516
10.1038/s41392-019-0080-7
10.18632/aging.203813
10.1186/s12943-018-0831-z
10.7150/thno.18133
ContentType Journal Article
Copyright 2022
Copyright © 2022. Published by Elsevier Inc.
Copyright_xml – notice: 2022
– notice: Copyright © 2022. Published by Elsevier Inc.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.bcp.2022.115032
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2968
ExternalDocumentID 35395241
10_1016_j_bcp_2022_115032
S0006295222001265
Genre Journal Article
Review
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.HR
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYJJ
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABWVN
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACNCT
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AFFNX
AFJKZ
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIKHN
AITUG
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IH2
IHE
J1W
K-O
KOM
L7B
LPU
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSH
SSP
SSZ
T5K
TEORI
TWZ
VH1
WH7
WUQ
X7M
ZGI
ZXP
~G-
AAYWO
AAYXX
ACLOT
ACVFH
ADCNI
AEUPX
AFPUW
AGQPQ
AIGII
AIIUN
AKBMS
AKYEP
APXCP
CITATION
EFKBS
EFLBG
~HD
AGCQF
AGRNS
NPM
7X8
ID FETCH-LOGICAL-c353t-7879d6b8510956c4c7c00e34ef2068a5d80924c109a8880906494c1aa31106b63
IEDL.DBID .~1
ISSN 0006-2952
1873-2968
IngestDate Wed Oct 01 13:56:23 EDT 2025
Mon Jul 21 06:00:38 EDT 2025
Thu Apr 24 22:57:06 EDT 2025
Wed Oct 01 05:26:55 EDT 2025
Sun Apr 06 06:54:37 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Therapy
ceRNA
NAFLD
lncRNA
Hepatocellular carcinoma
mRNA
Exosomes
ncRNAs
ctDNA
TAMs
MREs
RNA SEQ
miRNA
HBV
CTCs
LncRNAs
qRT-PCR
HCC
EMT
TME
IL-6
PPIs
IPSCs
LC
HCV
HSCs
CHB
HUVECs
Language English
License Copyright © 2022. Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-7879d6b8510956c4c7c00e34ef2068a5d80924c109a8880906494c1aa31106b63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 35395241
PQID 2648894920
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2648894920
pubmed_primary_35395241
crossref_citationtrail_10_1016_j_bcp_2022_115032
crossref_primary_10_1016_j_bcp_2022_115032
elsevier_sciencedirect_doi_10_1016_j_bcp_2022_115032
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2022
2022-06-00
2022-Jun
20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Biochemical pharmacology
PublicationTitleAlternate Biochem Pharmacol
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Zhang, Yang, Qi, Gao, Wei, Han (b0375) 2018; 21
Xin, Wu, Meng, Wang, Lu, Yang, Li, Zheng, Pu, Gui, Li, Li, Jia, Lu (b0335) 2018; 17
Budny, Kozlowski, Kaminska, Jankiewicz, Kolak, Budny, Budny, Niemunis-Sawicka, Szczypior, Kurniawka, Burdan (b0030) 2017; 43
Hasanin, Matboli, Seleem (b0355) 2020; 121
Zhu, Fu, Wu, Zheng (b0085) 2013; 56
Zhu, Feng, Liu, Wang (b0340) 2019; 41
Wang, Wang, Qin, Cai, Yu, Hu, Zeng (b0385) 2021; 17
Xie, Liu, Chen, Li, Zhong, Dai, Shao, Wu (b0055) 2020; 12
Kogure, Yan, Lin, Patel (b0235) 2013; 4
X.Z. Ding, S.Q. Zhang, X.L. Deng, J.H. Qiang, Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer, Technol. Cancer Res. Treat. 20 (2021) 1533033821990060.
Yu, Odenthal, Fries (b0050) 2016; 17
Li, Liu, Wang, Zhu, Zhao, Wang, Yang, Gurley, Chen, Hylemon, Zhou (b0300) 2020; 9
Ma, Gao, Liu, Lu, Ju, Zhang (b0275) 2020; 53
Seitz, Bataller, Cortez-Pinto, Gao, Gual, Lackner, Mathurin, Mueller, Szabo, Tsukamoto (b0230) 2018; 4
Wang, Zhu, Meng, He, Lu, Yan (b0125) 2019; 27
Takahashi, Yan, Haga, Patel (b0350) 2014; 127
Parola, Pinzani (b0220) 2019; 65
Sun, Yang, Zhou, Wang, Song, Li, Zhang, Xu, Xia, Chang, Liu, Yuan (b0100) 2018; 17
Huang, Gao, Qin, Lu (b0095) 2018; 314
Li, Yang, Yang, Li, Zhang, Zhou, Hu, Wang, Huang, Meng, Zhou, Zhang, Li, Xu (b0225) 2019; 865
Forner, Reig, Bruix (b0035) 2018; 391
Robinson, Covarrubias, Carpenter (b0070) 2020; 1863
Wang, Xing, Yang, Liu, Zhao, He, Ai, Yang (b0295) 2020; 9
Kim, Talati, Kim (b0005) 2017; 8
Kanda, Lau, Wei, Moriyama, Yu, Chuang, Ibrahim, Lesmana, Sollano, Kumar, Jindal, Sharma, Hamid, Kadir Dokmeci, Mamun Al, McCaughan, Wasim, Crawford, Kao, Ooka, Yokosuka, Sarin, Omata (b0020) 2019; 13
Li, Lei, Wu, Li (b0305) 2018; 19
Banini, Sanyal (b0395) 2019; 5
He, Yu, Xiong, Liu, Fan, Li, Chen, Chen, Xu (b0320) 2019; 719
Li, Liu, Cheng (b0045) 2019; 215
Yang, Shi, Xie, Wang, Sun, Liu, Zhao, Zhao, Wang, Ma, Malkoc, Chiang, Deng, Chen, Fu, Kwak, Fan, Kang, Yin, Rhee, Bertani, Otero, Lu, Yun, Lee, Jiang, Teng, Kim, Lee (b0060) 2020; 4
Wang, Fan, Zhang, Gao, Wang (b0210) 2014; 60
Cao, Zheng, Sun, Wang, Liu, Guo, Shen (b0245) 2019; 25
Takahashi, Yan, Wood, Haga, Patel (b0280) 2014; 12
Hu, Feng, Zhang, Zhao, Hu, Greshock, Zhang, Yang, Zhong, Wang, Jean, Li, Huang, Katsaros, Montone, Tanyi, Lu, Boyd, Nathanson, Li, Mills, Zhang (b0255) 2014; 26
Sasaki, Kanda, Yokosuka, Kato, Matsuoka, Moriyama (b0065) 2019; 20
Qing, Gu, Liu, Shen, Liu, Guang, Ke, Huang, Lee, Zhao (b0270) 2020; 13
Panzitt, Tschernatsch, Guelly, Moustafa, Stradner, Strohmaier, Buck, Denk, Schroeder, Trauner, Zatloukal (b0325) 2007; 132
Klinge (b0185) 2018; 4
Wortzel, Dror, Kenific, Lyden (b0195) 2019; 49
Wang, Xu, Jia, Wei (b0010) 2017; 49
Ke, Zhang, Huang, Li, Leng, Ye, Li (b0150) 2022; 9
Moldogazieva, Zavadskiy, Terentiev (b0400) 2021; 18
Sun, Zheng, Wang, Cai, Zheng, Hu, Lu, Xie, Zhang, Liu, Ye (b0145) 2022; 54
Li, Xu, Yu, He, Wang, Xu, Wang, Zhang, Zhang, Zhang, Yao, Shen (b0330) 2016; 7
Xie (b0025) 2017; 1018
Huang, Sun, Wen, Deng, Wan, He, Tian, Liang, Wei, Gao, Fu, Li, Jiang, Zhai, He (b0265) 2020; 111
Dai, Chen, Xue, Xiao, Mostofa, Wang, Chen, Xu, Sun, Li, Wei, Chen, Quamruzzaman, Zhang, Liu (b0310) 2019; 316
Li, Mao, Liu, Zhang, Tang, Guo (b0260) 2018; 197
Scarlotta, Simsek, Kim (b0390) 2019; 23
Li, Yin, Fan, Zhang, Yang (b0105) 2019; 4
Luo, Li, Wu, Chen (b0170) 2020; 23
Cao, Guo, Yan, Wu, Song (b0200) 2019; 71
Li, Kaslan, Lee, Yao, Gao (b0175) 2017; 7
Hewson, Capraro, Burdach, Whitaker, Morris (b0110) 2016; 1
Li, Zhou, Li, Xu, Cheng, Chen, Zheng (b0155) 2022; 14
Lu, Yuan, Li, Li, Liu, Wan (b0190) 2019; 12
Conigliaro, Costa, Lo Dico, Saieva, Buccheri, Dieli, Manno, Raccosta, Mancone, Tripodi, De Leo, Alessandro (b0290) 2015; 14
Dong, Wang, Chen, Zhang, Zou, Ye, He, Zhang, Han (b0080) 2018; 53
Li, Li (b0315) 2019; 50
Jia, Chen, Wang, Jayasinghe, Luo, Wei, Wang, Xiong, Chen, Xu, Hu, Wang, Zhao, Zhou (b0120) 2017; 8
Peng, Koirala, Mo (b0090) 2017; 36
Abd El Gwad, Matboli, El-Tawdi, Habib, Shehata, Ibrahim, Tash (b0370) 2018; 119
Hessvik, Llorente (b0180) 2018; 75
Liu, Li, Zhu, Wang, Zhao, Wang, Gurley, Liang, Chen, Lai, Pandak, Robert Lippman, Bajaj, Hylemon, Zhou (b0240) 2019; 70
Zhang, Li, Li, Li, Guo, Yao, Mi (b0160) 2015; 13
Zhao, Liu, Zhao, Che, Liu, Mei (b0135) 2022
Peng, Ye, Zhu, Xie, Zhong, Liu, Li, Xie (b0140) 2022; 2022
Gao, He, Wang, Wang, Wu, Hu, Ruan, Bo, Chen, Hu, Li, Zhang, Xia, Qian, Liu, Yang, Yang, Wang, Zhao (b0250) 2021; 30
Lee, Kim, Tak, Jang, Kweon, Park, Lee, Han, Chun, Park, Hur (b0365) 2019; 144
Matboli, ElGwad, Hasanin, El-Tawdi, Habib, Elmansy, Ibrahim, Shehata, Tash (b0285) 2019; 120
M. Di Maio, B. Daniele, C. Gallo, F. Perrone, Re: Design and endpoints of clinical trials in hepatocellular carcinoma, J. Natl. Cancer Inst. 100(21) (2008) 1557; author reply 1557-8.
Tanwar, Rhodes, Srivastava, Trembling, Rosenberg (b0215) 2020; 26
Loewer, Cabili, Guttman, Loh, Thomas, Park, Garber, Curran, Onder, Agarwal, Manos, Datta, Lander, Schlaeger, Daley, Rinn (b0345) 2010; 42
Zaghloul, Wahab, Seleem, Hanafy, Gomaa, Lakouz, Amin (b0015) 2019; 13
Zou, Lai, Zhang, Zheng, Xing, Li, Zou, Song, Zhao, Xia, Yang, Liu, Zhang, Cui, Jiang, Bai (b0165) 2019; 6
Yang, Liao, Tian, Li (b0115) 2017; 12
Ma, Zhang, Wen, Lin (b0075) 2018; 419
Xu, Chen, Dong, Wang (b0380) 2018; 27
Zhuo, Yi, Pu, Cen, Zhou, Feng, Wei, Chen, Wang, Bao, Wang, Tang (b0360) 2020; 12
Isin, Dalay (b0130) 2015; 444
Wang (10.1016/j.bcp.2022.115032_b0295) 2020; 9
Li (10.1016/j.bcp.2022.115032_b0330) 2016; 7
Sun (10.1016/j.bcp.2022.115032_b0100) 2018; 17
Cao (10.1016/j.bcp.2022.115032_b0245) 2019; 25
Yang (10.1016/j.bcp.2022.115032_b0115) 2017; 12
Wang (10.1016/j.bcp.2022.115032_b0385) 2021; 17
Budny (10.1016/j.bcp.2022.115032_b0030) 2017; 43
Jia (10.1016/j.bcp.2022.115032_b0120) 2017; 8
Abd El Gwad (10.1016/j.bcp.2022.115032_b0370) 2018; 119
Kanda (10.1016/j.bcp.2022.115032_b0020) 2019; 13
Seitz (10.1016/j.bcp.2022.115032_b0230) 2018; 4
Li (10.1016/j.bcp.2022.115032_b0315) 2019; 50
Ma (10.1016/j.bcp.2022.115032_b0075) 2018; 419
Peng (10.1016/j.bcp.2022.115032_b0090) 2017; 36
Gao (10.1016/j.bcp.2022.115032_b0250) 2021; 30
Xin (10.1016/j.bcp.2022.115032_b0335) 2018; 17
Li (10.1016/j.bcp.2022.115032_b0155) 2022; 14
Moldogazieva (10.1016/j.bcp.2022.115032_b0400) 2021; 18
Xu (10.1016/j.bcp.2022.115032_b0380) 2018; 27
Zaghloul (10.1016/j.bcp.2022.115032_b0015) 2019; 13
Xie (10.1016/j.bcp.2022.115032_b0025) 2017; 1018
Luo (10.1016/j.bcp.2022.115032_b0170) 2020; 23
Kim (10.1016/j.bcp.2022.115032_b0005) 2017; 8
Zou (10.1016/j.bcp.2022.115032_b0165) 2019; 6
Zhang (10.1016/j.bcp.2022.115032_b0160) 2015; 13
Li (10.1016/j.bcp.2022.115032_b0175) 2017; 7
Li (10.1016/j.bcp.2022.115032_b0305) 2018; 19
Cao (10.1016/j.bcp.2022.115032_b0200) 2019; 71
Liu (10.1016/j.bcp.2022.115032_b0240) 2019; 70
Li (10.1016/j.bcp.2022.115032_b0260) 2018; 197
Li (10.1016/j.bcp.2022.115032_b0225) 2019; 865
Robinson (10.1016/j.bcp.2022.115032_b0070) 2020; 1863
Zhao (10.1016/j.bcp.2022.115032_b0135) 2022
10.1016/j.bcp.2022.115032_b0040
Forner (10.1016/j.bcp.2022.115032_b0035) 2018; 391
Panzitt (10.1016/j.bcp.2022.115032_b0325) 2007; 132
Kogure (10.1016/j.bcp.2022.115032_b0235) 2013; 4
10.1016/j.bcp.2022.115032_b0205
Hasanin (10.1016/j.bcp.2022.115032_b0355) 2020; 121
Qing (10.1016/j.bcp.2022.115032_b0270) 2020; 13
Ke (10.1016/j.bcp.2022.115032_b0150) 2022; 9
Lu (10.1016/j.bcp.2022.115032_b0190) 2019; 12
Sasaki (10.1016/j.bcp.2022.115032_b0065) 2019; 20
Li (10.1016/j.bcp.2022.115032_b0300) 2020; 9
Huang (10.1016/j.bcp.2022.115032_b0265) 2020; 111
Xie (10.1016/j.bcp.2022.115032_b0055) 2020; 12
Matboli (10.1016/j.bcp.2022.115032_b0285) 2019; 120
He (10.1016/j.bcp.2022.115032_b0320) 2019; 719
Peng (10.1016/j.bcp.2022.115032_b0140) 2022; 2022
Sun (10.1016/j.bcp.2022.115032_b0145) 2022; 54
Huang (10.1016/j.bcp.2022.115032_b0095) 2018; 314
Dong (10.1016/j.bcp.2022.115032_b0080) 2018; 53
Loewer (10.1016/j.bcp.2022.115032_b0345) 2010; 42
Li (10.1016/j.bcp.2022.115032_b0045) 2019; 215
Ma (10.1016/j.bcp.2022.115032_b0275) 2020; 53
Zhu (10.1016/j.bcp.2022.115032_b0340) 2019; 41
Wang (10.1016/j.bcp.2022.115032_b0125) 2019; 27
Takahashi (10.1016/j.bcp.2022.115032_b0350) 2014; 127
Banini (10.1016/j.bcp.2022.115032_b0395) 2019; 5
Zhu (10.1016/j.bcp.2022.115032_b0085) 2013; 56
Conigliaro (10.1016/j.bcp.2022.115032_b0290) 2015; 14
Wortzel (10.1016/j.bcp.2022.115032_b0195) 2019; 49
Scarlotta (10.1016/j.bcp.2022.115032_b0390) 2019; 23
Dai (10.1016/j.bcp.2022.115032_b0310) 2019; 316
Parola (10.1016/j.bcp.2022.115032_b0220) 2019; 65
Klinge (10.1016/j.bcp.2022.115032_b0185) 2018; 4
Li (10.1016/j.bcp.2022.115032_b0105) 2019; 4
Tanwar (10.1016/j.bcp.2022.115032_b0215) 2020; 26
Hu (10.1016/j.bcp.2022.115032_b0255) 2014; 26
Yu (10.1016/j.bcp.2022.115032_b0050) 2016; 17
Yang (10.1016/j.bcp.2022.115032_b0060) 2020; 4
Wang (10.1016/j.bcp.2022.115032_b0010) 2017; 49
Zhuo (10.1016/j.bcp.2022.115032_b0360) 2020; 12
Lee (10.1016/j.bcp.2022.115032_b0365) 2019; 144
Wang (10.1016/j.bcp.2022.115032_b0210) 2014; 60
Hewson (10.1016/j.bcp.2022.115032_b0110) 2016; 1
Takahashi (10.1016/j.bcp.2022.115032_b0280) 2014; 12
Hessvik (10.1016/j.bcp.2022.115032_b0180) 2018; 75
Isin (10.1016/j.bcp.2022.115032_b0130) 2015; 444
Zhang (10.1016/j.bcp.2022.115032_b0375) 2018; 21
References_xml – volume: 14
  start-page: 368
  year: 2022
  end-page: 388
  ident: b0155
  article-title: LINC02362 attenuates hepatocellular carcinoma progression through the miR-516b-5p/SOSC2 axis
  publication-title: Aging (Albany NY)
– volume: 719
  year: 2019
  ident: b0320
  article-title: Exosomes derived from liver cancer cells reprogram biological behaviors of LO2 cells by transferring Linc-ROR
  publication-title: Gene
– volume: 316
  start-page: 73
  year: 2019
  end-page: 84
  ident: b0310
  article-title: Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite
  publication-title: Toxicol. Lett.
– volume: 1
  start-page: 3
  year: 2016
  end-page: 11
  ident: b0110
  article-title: Extracellular vesicle associated long non-coding RNAs functionally enhance cell viability
  publication-title: Non-coding RNA research
– volume: 17
  start-page: 94
  year: 2018
  ident: b0335
  article-title: Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a
  publication-title: Mol. Cancer
– volume: 4
  start-page: 16
  year: 2018
  ident: b0230
  article-title: Alcoholic liver disease
  publication-title: Nat. Rev. Dis. Primers
– volume: 132
  start-page: 330
  year: 2007
  end-page: 342
  ident: b0325
  article-title: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA
  publication-title: Gastroenterology
– volume: 13
  start-page: 108
  year: 2019
  end-page: 113
  ident: b0015
  article-title: Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis
  publication-title: Drug Discov. Ther.
– volume: 71
  start-page: 1846
  year: 2019
  end-page: 1856
  ident: b0200
  article-title: Exosomal long noncoding RNAs in aging and age-related diseases
  publication-title: IUBMB Life
– volume: 23
  start-page: 999
  year: 2020
  end-page: 1006
  ident: b0170
  article-title: Advances of Exosomes Extraction and Its Mechanism in Early Diagnosis of Lung Cancer
  publication-title: Zhongguo Fei Ai Za Zhi
– volume: 21
  start-page: 651
  year: 2018
  end-page: 659
  ident: b0375
  article-title: lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma
  publication-title: Cancer Biomark.
– volume: 391
  start-page: 1301
  year: 2018
  end-page: 1314
  ident: b0035
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
– volume: 215
  start-page: 152468
  year: 2019
  ident: b0045
  article-title: Exosome plays an important role in the development of hepatocellular carcinoma
  publication-title: Pathol. Res. Pract.
– volume: 2022
  start-page: 9631036
  year: 2022
  ident: b0140
  article-title: LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining beta-Catenin in the Nucleus to Augment Wnt Signaling
  publication-title: Biomed Res. Int.
– volume: 144
  start-page: 1444
  year: 2019
  end-page: 1452
  ident: b0365
  article-title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
  publication-title: Int. J. Cancer
– volume: 43
  start-page: 133
  year: 2017
  end-page: 139
  ident: b0030
  article-title: Epidemiology and risk factors of hepatocellular carcinoma
  publication-title: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
– volume: 41
  start-page: 659
  year: 2019
  end-page: 666
  ident: b0340
  article-title: LncRNA HULC promots HCC growth by downregulating miR-29
  publication-title: Zhonghua Zhong Liu Za Zhi
– volume: 12
  start-page: 68
  year: 2019
  end-page: 74
  ident: b0190
  article-title: The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application
  publication-title: J. Cardiovasc. Transl. Res.
– volume: 121
  start-page: 1295
  year: 2020
  end-page: 1306
  ident: b0355
  article-title: Hesperidin suppressed hepatic precancerous lesions via modulation of exophagy in rats
  publication-title: J. Cell. Biochem.
– volume: 111
  start-page: 3338
  year: 2020
  end-page: 3349
  ident: b0265
  article-title: RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma
  publication-title: Cancer Sci.
– volume: 53
  start-page: 1013
  year: 2018
  end-page: 1026
  ident: b0080
  article-title: Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer
  publication-title: Int. J. Oncol.
– volume: 4
  start-page: 69
  year: 2020
  end-page: 83
  ident: b0060
  article-title: Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
  publication-title: Nat. Biomed. Eng.
– volume: 444
  start-page: 280
  year: 2015
  end-page: 288
  ident: b0130
  article-title: LncRNAs and neoplasia
  publication-title: Clin. Chim. Acta
– volume: 27
  start-page: 710
  year: 2018
  end-page: 716
  ident: b0380
  article-title: Serum Exosomal Long Noncoding RNAs ENSG00000258332.1 and LINC00635 for the Diagnosis and Prognosis of Hepatocellular Carcinoma
  publication-title: Cancer Epidemiol. Biomarkers Prev.
– volume: 19
  year: 2018
  ident: b0305
  article-title: Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339
  publication-title: Int. J. Mol. Sci.
– volume: 120
  start-page: 14946
  year: 2019
  end-page: 14959
  ident: b0285
  article-title: Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2-acetamidofluorene
  publication-title: J. Cell. Biochem.
– volume: 419
  start-page: 27
  year: 2018
  end-page: 29
  ident: b0075
  article-title: Membrane-lipid associated lncRNA: A new regulator in cancer signaling
  publication-title: Cancer Lett.
– volume: 65
  start-page: 37
  year: 2019
  end-page: 55
  ident: b0220
  article-title: Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
  publication-title: Mol. Aspects Med.
– volume: 14
  start-page: 155
  year: 2015
  ident: b0290
  article-title: CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
  publication-title: Mol. Cancer
– volume: 25
  start-page: 5283
  year: 2019
  end-page: 5299
  ident: b0245
  article-title: Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion
  publication-title: World J. Gastroenterol.
– volume: 7
  start-page: 42431
  year: 2016
  end-page: 42446
  ident: b0330
  article-title: LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway
  publication-title: Oncotarget
– volume: 12
  start-page: 26236
  year: 2020
  end-page: 26247
  ident: b0360
  article-title: Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765
  publication-title: Aging (Albany NY)
– volume: 56
  start-page: 876
  year: 2013
  end-page: 885
  ident: b0085
  article-title: Function of lncRNAs and approaches to lncRNA-protein interactions
  publication-title: Science China. Life Sci.
– volume: 54
  start-page: 1
  year: 2022
  end-page: 10
  ident: b0145
  article-title: LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells
  publication-title: Acta Biochim. Biophys. Sin. (Shanghai)
– volume: 4
  start-page: 40
  year: 2018
  ident: b0185
  article-title: Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
  publication-title: Non-coding RNA
– volume: 13
  start-page: 17
  year: 2015
  end-page: 24
  ident: b0160
  article-title: Exosome and exosomal microRNA: trafficking, sorting, and function
  publication-title: Genomics, proteomics & bioinformatics
– volume: 7
  start-page: 789
  year: 2017
  end-page: 804
  ident: b0175
  article-title: Progress in Exosome Isolation Techniques
  publication-title: Theranostics
– volume: 12
  start-page: 1377
  year: 2014
  end-page: 1387
  ident: b0280
  article-title: Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy
  publication-title: Mol. Cancer Res.
– reference: M. Di Maio, B. Daniele, C. Gallo, F. Perrone, Re: Design and endpoints of clinical trials in hepatocellular carcinoma, J. Natl. Cancer Inst. 100(21) (2008) 1557; author reply 1557-8.
– volume: 4
  start-page: 261
  year: 2013
  end-page: 272
  ident: b0235
  article-title: Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer
  publication-title: Genes Cancer
– volume: 197
  start-page: 122
  year: 2018
  end-page: 129
  ident: b0260
  article-title: LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells
  publication-title: Life Sci.
– volume: 30
  start-page: 113
  year: 2021
  end-page: 119
  ident: b0250
  article-title: All-trans retinoic acid suppressed GES-1 cell proliferation induced by exosomes from patients with precancerous lesions by arresting the cell cycle in S-phase
  publication-title: Eur. J. Cancer Prev.
– volume: 12
  start-page: 708
  year: 2020
  end-page: 716
  ident: b0055
  article-title: Role of MicroRNA, LncRNA, and Exosomes in the Progression of Osteoarthritis: A Review of Recent Literature
  publication-title: Orthop. Surg.
– volume: 42
  start-page: 1113
  year: 2010
  end-page: 1117
  ident: b0345
  article-title: Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells
  publication-title: Nat. Genet.
– volume: 1863
  start-page: 194419
  year: 2020
  ident: b0070
  article-title: The how and why of lncRNA function: An innate immune perspective
  publication-title: Biochim. Biophys. Acta, Gene Regul. Mech.
– volume: 23
  start-page: 284
  year: 2019
  end-page: 296
  ident: b0390
  article-title: Liquid Biopsy in Solid Malignancy
  publication-title: Genet. Test. Mol. Biomarkers
– volume: 1018
  start-page: 11
  year: 2017
  end-page: 21
  ident: b0025
  article-title: Hepatitis B Virus-Associated Hepatocellular Carcinoma
  publication-title: Adv. Exp. Med. Biol.
– volume: 127
  start-page: 1585
  year: 2014
  end-page: 1594
  ident: b0350
  article-title: Modulation of hypoxia-signaling pathways by extracellular linc-RoR
  publication-title: J. Cell Sci.
– volume: 314
  start-page: G559
  year: 2018
  end-page: G565
  ident: b0095
  article-title: lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
– volume: 13
  start-page: 12521
  year: 2020
  end-page: 12538
  ident: b0270
  article-title: Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer
  publication-title: Onco Targets Ther.
– volume: 4
  start-page: 47
  year: 2019
  ident: b0105
  article-title: The roles of exosomal miRNAs and lncRNAs in lung diseases
  publication-title: Signal Transduction Targeted Therapy
– year: 2022
  ident: b0135
  article-title: Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression
  publication-title: Tumori
– volume: 49
  start-page: 347
  year: 2019
  end-page: 360
  ident: b0195
  article-title: Exosome-Mediated Metastasis: Communication from a Distance
  publication-title: Dev. Cell
– volume: 12
  year: 2017
  ident: b0115
  article-title: Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies
  publication-title: Biotechnol. J.
– volume: 17
  start-page: 2028
  year: 2016
  ident: b0050
  article-title: Exosomes as miRNA Carriers: Formation-Function-Future
  publication-title: Int. J. Mol. Sci.
– volume: 70
  start-page: 1317
  year: 2019
  end-page: 1335
  ident: b0240
  article-title: Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis
  publication-title: Hepatology
– volume: 17
  start-page: 82
  year: 2018
  ident: b0100
  article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
  publication-title: Mol. Cancer
– volume: 18
  start-page: 369
  year: 2021
  end-page: 383
  ident: b0400
  article-title: Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine
  publication-title: Cancer Genomics Proteomics
– volume: 865
  year: 2019
  ident: b0225
  article-title: ZEB1 regulates the activation of hepatic stellate cells through Wnt/beta-catenin signaling pathway
  publication-title: Eur. J. Pharmacol.
– volume: 9
  year: 2022
  ident: b0150
  article-title: Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation
  publication-title: Front Cardiovasc Med
– volume: 26
  start-page: 344
  year: 2014
  end-page: 357
  ident: b0255
  article-title: A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer
  publication-title: Cancer Cell
– volume: 26
  start-page: 109
  year: 2020
  end-page: 133
  ident: b0215
  article-title: Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
  publication-title: World J. Gastroenterol.
– volume: 17
  start-page: 291
  year: 2021
  end-page: 306
  ident: b0385
  article-title: The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
  publication-title: Expert Opin. Drug Metab. Toxicol.
– volume: 13
  start-page: 649
  year: 2019
  end-page: 661
  ident: b0020
  article-title: APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
  publication-title: Hep. Intl.
– volume: 8
  start-page: 256
  year: 2017
  end-page: 265
  ident: b0005
  article-title: Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
  publication-title: J. Gastrointest. Oncol.
– volume: 60
  start-page: 2099
  year: 2014
  end-page: 2108
  ident: b0210
  article-title: The global burden of liver disease: the major impact of China
  publication-title: Hepatology
– volume: 20
  start-page: 1406
  year: 2019
  ident: b0065
  article-title: Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
  publication-title: Int. J. Mol. Sci.
– volume: 27
  start-page: 1718
  year: 2019
  end-page: 1725
  ident: b0125
  article-title: ncRNA-Encoded Peptides or Proteins and Cancer
  publication-title: Mol. Ther.
– volume: 9
  year: 2020
  ident: b0300
  article-title: Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions
  publication-title: Cells
– volume: 6
  start-page: 1801313
  year: 2019
  ident: b0165
  article-title: Exosome Release Is Regulated by mTORC1
  publication-title: Adv. Sci. (Weinh)
– volume: 8
  start-page: 41717
  year: 2017
  end-page: 41733
  ident: b0120
  article-title: Exosome: emerging biomarker in breast cancer
  publication-title: Oncotarget
– volume: 75
  start-page: 193
  year: 2018
  end-page: 208
  ident: b0180
  article-title: Current knowledge on exosome biogenesis and release
  publication-title: Cell. Mol. Life Sci.
– volume: 9
  start-page: 7218
  year: 2020
  end-page: 7230
  ident: b0295
  article-title: Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis
  publication-title: Cancer Med
– volume: 50
  start-page: 177
  year: 2019
  end-page: 181
  ident: b0315
  article-title: LINC ROR from Hepatocarcinoma Cell-derived Exosomes Modulates Inflammation in Human Macrophages
  publication-title: Sichuan Da Xue Xue Bao Yi Xue Ban
– volume: 5
  year: 2019
  ident: b0395
  article-title: The use of cell free DNA in the diagnosis of HCC
  publication-title: Hepatoma research
– volume: 53
  year: 2020
  ident: b0275
  article-title: Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation
  publication-title: Cell Prolif.
– volume: 49
  start-page: 383
  year: 2017
  end-page: 391
  ident: b0010
  article-title: MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1
  publication-title: Acta Biochimica Biophysica Sinica
– volume: 36
  start-page: 5661
  year: 2017
  end-page: 5667
  ident: b0090
  article-title: LncRNA-mediated regulation of cell signaling in cancer
  publication-title: Oncogene
– volume: 119
  start-page: 8600
  year: 2018
  end-page: 8610
  ident: b0370
  article-title: Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma
  publication-title: J. Cell. Biochem.
– reference: X.Z. Ding, S.Q. Zhang, X.L. Deng, J.H. Qiang, Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer, Technol. Cancer Res. Treat. 20 (2021) 1533033821990060.
– volume: 215
  start-page: 152468
  issue: 8
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0045
  article-title: Exosome plays an important role in the development of hepatocellular carcinoma
  publication-title: Pathol. Res. Pract.
  doi: 10.1016/j.prp.2019.152468
– volume: 121
  start-page: 1295
  issue: 2
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0355
  article-title: Hesperidin suppressed hepatic precancerous lesions via modulation of exophagy in rats
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.29363
– volume: 8
  start-page: 256
  issue: 2
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0005
  article-title: Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
  publication-title: J. Gastrointest. Oncol.
  doi: 10.21037/jgo.2016.09.07
– volume: 27
  start-page: 1718
  issue: 10
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0125
  article-title: ncRNA-Encoded Peptides or Proteins and Cancer
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2019.09.001
– volume: 7
  start-page: 42431
  issue: 27
  year: 2016
  ident: 10.1016/j.bcp.2022.115032_b0330
  article-title: LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9883
– volume: 41
  start-page: 659
  issue: 9
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0340
  article-title: LncRNA HULC promots HCC growth by downregulating miR-29
  publication-title: Zhonghua Zhong Liu Za Zhi
– volume: 65
  start-page: 37
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0220
  article-title: Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
  publication-title: Mol. Aspects Med.
  doi: 10.1016/j.mam.2018.09.002
– volume: 17
  start-page: 291
  issue: 3
  year: 2021
  ident: 10.1016/j.bcp.2022.115032_b0385
  article-title: The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
  publication-title: Expert Opin. Drug Metab. Toxicol.
  doi: 10.1080/17425255.2021.1887139
– volume: 18
  start-page: 369
  issue: 3 Suppl
  year: 2021
  ident: 10.1016/j.bcp.2022.115032_b0400
  article-title: Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine
  publication-title: Cancer Genomics Proteomics
  doi: 10.21873/cgp.20266
– volume: 17
  start-page: 94
  issue: 1
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0335
  article-title: Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-018-0843-8
– volume: 8
  start-page: 41717
  issue: 25
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0120
  article-title: Exosome: emerging biomarker in breast cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16684
– volume: 4
  start-page: 16
  issue: 1
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0230
  article-title: Alcoholic liver disease
  publication-title: Nat. Rev. Dis. Primers
  doi: 10.1038/s41572-018-0014-7
– volume: 26
  start-page: 109
  issue: 2
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0215
  article-title: Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v26.i2.109
– volume: 19
  issue: 10
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0305
  article-title: Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19102958
– volume: 13
  start-page: 649
  issue: 6
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0020
  article-title: APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
  publication-title: Hep. Intl.
  doi: 10.1007/s12072-019-09988-7
– volume: 119
  start-page: 8600
  issue: 10
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0370
  article-title: Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.27109
– volume: 1
  start-page: 3
  issue: 1
  year: 2016
  ident: 10.1016/j.bcp.2022.115032_b0110
  article-title: Extracellular vesicle associated long non-coding RNAs functionally enhance cell viability
  publication-title: Non-coding RNA research
  doi: 10.1016/j.ncrna.2016.06.001
– volume: 13
  start-page: 12521
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0270
  article-title: Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer
  publication-title: Onco Targets Ther.
  doi: 10.2147/OTT.S284167
– volume: 316
  start-page: 73
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0310
  article-title: Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2019.09.008
– volume: 53
  start-page: 1013
  issue: 3
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0080
  article-title: Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer
  publication-title: Int. J. Oncol.
– volume: 4
  start-page: 40
  issue: 4
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0185
  article-title: Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
  publication-title: Non-coding RNA
  doi: 10.3390/ncrna4040040
– volume: 4
  start-page: 261
  issue: 7–8
  year: 2013
  ident: 10.1016/j.bcp.2022.115032_b0235
  article-title: Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer
  publication-title: Genes Cancer
  doi: 10.1177/1947601913499020
– volume: 75
  start-page: 193
  issue: 2
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0180
  article-title: Current knowledge on exosome biogenesis and release
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-017-2595-9
– volume: 13
  start-page: 108
  issue: 2
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0015
  article-title: Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis
  publication-title: Drug Discov. Ther.
  doi: 10.5582/ddt.2019.01009
– volume: 865
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0225
  article-title: ZEB1 regulates the activation of hepatic stellate cells through Wnt/beta-catenin signaling pathway
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2019.172787
– volume: 314
  start-page: G559
  issue: 5
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0095
  article-title: lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.00242.2017
– volume: 419
  start-page: 27
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0075
  article-title: Membrane-lipid associated lncRNA: A new regulator in cancer signaling
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2018.01.008
– volume: 12
  issue: 4
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0115
  article-title: Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.201600699
– volume: 56
  start-page: 876
  issue: 10
  year: 2013
  ident: 10.1016/j.bcp.2022.115032_b0085
  article-title: Function of lncRNAs and approaches to lncRNA-protein interactions
  publication-title: Science China. Life Sci.
  doi: 10.1007/s11427-013-4553-6
– ident: 10.1016/j.bcp.2022.115032_b0205
  doi: 10.1177/1533033821990060
– volume: 1018
  start-page: 11
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0025
  article-title: Hepatitis B Virus-Associated Hepatocellular Carcinoma
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-981-10-5765-6_2
– volume: 5
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0395
  article-title: The use of cell free DNA in the diagnosis of HCC
  publication-title: Hepatoma research
– volume: 14
  start-page: 155
  year: 2015
  ident: 10.1016/j.bcp.2022.115032_b0290
  article-title: CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-015-0426-x
– volume: 9
  start-page: 7218
  issue: 19
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0295
  article-title: Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis
  publication-title: Cancer Med
  doi: 10.1002/cam4.3313
– ident: 10.1016/j.bcp.2022.115032_b0040
  doi: 10.1093/jnci/djn341
– volume: 49
  start-page: 383
  issue: 5
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0010
  article-title: MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1
  publication-title: Acta Biochimica Biophysica Sinica
  doi: 10.1093/abbs/gmx017
– volume: 53
  issue: 9
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0275
  article-title: Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12795
– volume: 23
  start-page: 284
  issue: 4
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0390
  article-title: Liquid Biopsy in Solid Malignancy
  publication-title: Genet. Test. Mol. Biomarkers
  doi: 10.1089/gtmb.2018.0237
– volume: 1863
  start-page: 194419
  issue: 4
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0070
  article-title: The how and why of lncRNA function: An innate immune perspective
  publication-title: Biochim. Biophys. Acta, Gene Regul. Mech.
  doi: 10.1016/j.bbagrm.2019.194419
– volume: 60
  start-page: 2099
  issue: 6
  year: 2014
  ident: 10.1016/j.bcp.2022.115032_b0210
  article-title: The global burden of liver disease: the major impact of China
  publication-title: Hepatology
  doi: 10.1002/hep.27406
– volume: 27
  start-page: 710
  issue: 6
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0380
  article-title: Serum Exosomal Long Noncoding RNAs ENSG00000258332.1 and LINC00635 for the Diagnosis and Prognosis of Hepatocellular Carcinoma
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-17-0770
– volume: 13
  start-page: 17
  issue: 1
  year: 2015
  ident: 10.1016/j.bcp.2022.115032_b0160
  article-title: Exosome and exosomal microRNA: trafficking, sorting, and function
  publication-title: Genomics, proteomics & bioinformatics
  doi: 10.1016/j.gpb.2015.02.001
– volume: 21
  start-page: 651
  issue: 3
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0375
  article-title: lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma
  publication-title: Cancer Biomark.
  doi: 10.3233/CBM-170727
– volume: 6
  start-page: 1801313
  issue: 3
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0165
  article-title: Exosome Release Is Regulated by mTORC1
  publication-title: Adv. Sci. (Weinh)
  doi: 10.1002/advs.201801313
– volume: 197
  start-page: 122
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0260
  article-title: LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2018.02.006
– volume: 49
  start-page: 347
  issue: 3
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0195
  article-title: Exosome-Mediated Metastasis: Communication from a Distance
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2019.04.011
– volume: 30
  start-page: 113
  issue: 1
  year: 2021
  ident: 10.1016/j.bcp.2022.115032_b0250
  article-title: All-trans retinoic acid suppressed GES-1 cell proliferation induced by exosomes from patients with precancerous lesions by arresting the cell cycle in S-phase
  publication-title: Eur. J. Cancer Prev.
  doi: 10.1097/CEJ.0000000000000571
– volume: 17
  start-page: 2028
  issue: 12
  year: 2016
  ident: 10.1016/j.bcp.2022.115032_b0050
  article-title: Exosomes as miRNA Carriers: Formation-Function-Future
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17122028
– volume: 9
  year: 2022
  ident: 10.1016/j.bcp.2022.115032_b0150
  article-title: Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2022.791156
– volume: 12
  start-page: 1377
  issue: 10
  year: 2014
  ident: 10.1016/j.bcp.2022.115032_b0280
  article-title: Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-13-0636
– volume: 26
  start-page: 344
  issue: 3
  year: 2014
  ident: 10.1016/j.bcp.2022.115032_b0255
  article-title: A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.07.009
– volume: 12
  start-page: 708
  issue: 3
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0055
  article-title: Role of MicroRNA, LncRNA, and Exosomes in the Progression of Osteoarthritis: A Review of Recent Literature
  publication-title: Orthop. Surg.
  doi: 10.1111/os.12690
– volume: 4
  start-page: 69
  issue: 1
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0060
  article-title: Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-019-0485-1
– volume: 23
  start-page: 999
  issue: 11
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0170
  article-title: Advances of Exosomes Extraction and Its Mechanism in Early Diagnosis of Lung Cancer
  publication-title: Zhongguo Fei Ai Za Zhi
– year: 2022
  ident: 10.1016/j.bcp.2022.115032_b0135
  article-title: Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression
  publication-title: Tumori
– volume: 127
  start-page: 1585
  issue: Pt 7
  year: 2014
  ident: 10.1016/j.bcp.2022.115032_b0350
  article-title: Modulation of hypoxia-signaling pathways by extracellular linc-RoR
  publication-title: J. Cell Sci.
– volume: 120
  start-page: 14946
  issue: 9
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0285
  article-title: Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2-acetamidofluorene
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.28757
– volume: 12
  start-page: 26236
  issue: 24
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0360
  article-title: Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.202430
– volume: 25
  start-page: 5283
  issue: 35
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0245
  article-title: Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v25.i35.5283
– volume: 144
  start-page: 1444
  issue: 6
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0365
  article-title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31931
– volume: 36
  start-page: 5661
  issue: 41
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0090
  article-title: LncRNA-mediated regulation of cell signaling in cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2017.184
– volume: 42
  start-page: 1113
  issue: 12
  year: 2010
  ident: 10.1016/j.bcp.2022.115032_b0345
  article-title: Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells
  publication-title: Nat. Genet.
  doi: 10.1038/ng.710
– volume: 50
  start-page: 177
  issue: 2
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0315
  article-title: LINC ROR from Hepatocarcinoma Cell-derived Exosomes Modulates Inflammation in Human Macrophages
  publication-title: Sichuan Da Xue Xue Bao Yi Xue Ban
– volume: 391
  start-page: 1301
  issue: 10127
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0035
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)30010-2
– volume: 12
  start-page: 68
  issue: 1
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0190
  article-title: The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application
  publication-title: J. Cardiovasc. Transl. Res.
  doi: 10.1007/s12265-018-9796-y
– volume: 70
  start-page: 1317
  issue: 4
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0240
  article-title: Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis
  publication-title: Hepatology
  doi: 10.1002/hep.30662
– volume: 444
  start-page: 280
  year: 2015
  ident: 10.1016/j.bcp.2022.115032_b0130
  article-title: LncRNAs and neoplasia
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2015.02.046
– volume: 43
  start-page: 133
  issue: 255
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0030
  article-title: Epidemiology and risk factors of hepatocellular carcinoma
  publication-title: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
– volume: 20
  start-page: 1406
  issue: 6
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0065
  article-title: Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20061406
– volume: 132
  start-page: 330
  issue: 1
  year: 2007
  ident: 10.1016/j.bcp.2022.115032_b0325
  article-title: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.08.026
– volume: 9
  issue: 1
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0300
  article-title: Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions
  publication-title: Cells
  doi: 10.3390/cells9010190
– volume: 719
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0320
  article-title: Exosomes derived from liver cancer cells reprogram biological behaviors of LO2 cells by transferring Linc-ROR
  publication-title: Gene
  doi: 10.1016/j.gene.2019.144044
– volume: 2022
  start-page: 9631036
  year: 2022
  ident: 10.1016/j.bcp.2022.115032_b0140
  article-title: LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining beta-Catenin in the Nucleus to Augment Wnt Signaling
  publication-title: Biomed Res. Int.
  doi: 10.1155/2022/9631036
– volume: 54
  start-page: 1
  issue: 2
  year: 2022
  ident: 10.1016/j.bcp.2022.115032_b0145
  article-title: LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells
  publication-title: Acta Biochim. Biophys. Sin. (Shanghai)
  doi: 10.3724/abbs.2021019
– volume: 71
  start-page: 1846
  issue: 12
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0200
  article-title: Exosomal long noncoding RNAs in aging and age-related diseases
  publication-title: IUBMB Life
  doi: 10.1002/iub.2141
– volume: 111
  start-page: 3338
  issue: 9
  year: 2020
  ident: 10.1016/j.bcp.2022.115032_b0265
  article-title: RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma
  publication-title: Cancer Sci.
  doi: 10.1111/cas.14516
– volume: 4
  start-page: 47
  year: 2019
  ident: 10.1016/j.bcp.2022.115032_b0105
  article-title: The roles of exosomal miRNAs and lncRNAs in lung diseases
  publication-title: Signal Transduction Targeted Therapy
  doi: 10.1038/s41392-019-0080-7
– volume: 14
  start-page: 368
  issue: 1
  year: 2022
  ident: 10.1016/j.bcp.2022.115032_b0155
  article-title: LINC02362 attenuates hepatocellular carcinoma progression through the miR-516b-5p/SOSC2 axis
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.203813
– volume: 17
  start-page: 82
  issue: 1
  year: 2018
  ident: 10.1016/j.bcp.2022.115032_b0100
  article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-018-0831-z
– volume: 7
  start-page: 789
  issue: 3
  year: 2017
  ident: 10.1016/j.bcp.2022.115032_b0175
  article-title: Progress in Exosome Isolation Techniques
  publication-title: Theranostics
  doi: 10.7150/thno.18133
SSID ssj0006861
Score 2.442587
SecondaryResourceType review_article
Snippet [Display omitted] Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidences of HCC and HCC-related deaths have increased over...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 115032
SubjectTerms Exosomes
Hepatocellular carcinoma
LncRNAs
Therapy
Title Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice
URI https://dx.doi.org/10.1016/j.bcp.2022.115032
https://www.ncbi.nlm.nih.gov/pubmed/35395241
https://www.proquest.com/docview/2648894920
Volume 200
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1873-2968
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006861
  issn: 0006-2952
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1873-2968
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006861
  issn: 0006-2952
  databaseCode: ACRLP
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Science Direct
  customDbUrl:
  eissn: 1873-2968
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006861
  issn: 0006-2952
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1873-2968
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006861
  issn: 0006-2952
  databaseCode: AIKHN
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1873-2968
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006861
  issn: 0006-2952
  databaseCode: AKRWK
  dateStart: 19930101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLYQHOCCYLzGS0FCHBCF0mRZy22amMZrQggEtyhJOzHE2okViV347dhtw8QBDhzbOm1kp_aX9rMNsI-gt-8bIT1rjPREnze9iJvY6yehTkIeWlsU07npye6DuHxqPM1A2-XCEK2y8v2lTy-8dXXmpNLmyWgwoBxfXwYR4geiBQWSEs2FaFIXg-PPKc1DhrLqmic9knZ_NguOl7FUsjIIjgkX8eC32PQb9ixiUGcJFivwyFrl_JZhJklrMN92PdtqcHBbVqKeHLH7aWLV-IgdsNtpjerJCjyef2TjbIg3u07tXa81ZjqN2TPGpjyjb_lETmVt6jOUotQZ67xlQ4YRb2BZVR7omeUZc3mVzCVbrcJD5_y-3fWqHgue5Q2ee_i-RrE0iLuoIqEVtml9P-Ei6QeoOt2IQx93aBavatwr-xEimAgPteaIG6SRfA1m0yxNNoCZmLALSclYcMO1QTDA0RNrcRqJOK6D77SrbFWAnPpgvCrHNHtRaBBFBlGlQepw-D1kVFbf-EtYOJOpH0tIYXT4a9ieM69Ca5GOdZpk72NF5L8wElHg12G9tPv3LFB5uJjE6eb_HroFC3RUcs62YTZ_e092EN3kZrdYvrsw17q46va-ADnP9T4
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1RT9swED4xeGAviDE2CtvwpKkPiJQQO26yN1RRFVYqhIrom2U7qSiiSUWDBC_89t0lMRUP9IHHJOfEunPuPid33wH8QdA79o2QnjVGemLM217MTeKN00inEY-sLcl0Lgaydy3OR-FoBTquFobSKmvfX_n00lvXZ45qbR7NJhOq8fVlECN-oLSgQIafYE2EQZt2YK2XRZ6HjGTdNk96JO5-bZZJXsYSZ2UQtAgY8eC94PQe-CyDUHcTNmr0yE6qCX6BlTTbgvWOa9q2Bc3Lior6-ZANF5VV80PWZJcLkurnr3Bz-pTP8ynerJ_Zq8HJnOksYbcYnIqcPuZTdirrUKOhDKX-su5DPmUY8iaW1fxAt6zImSusZK7aahuuu6fDTs-rmyx4loe88PCFjRNpEHgRJaEVtm19P-UiHQeoOh0mkY9bNItXNW6W_RghTIyHWnMEDtJI_g1WszxLd4CZhMALSclEcMO1QTTA0RVrcRyLJGmA77SrbM1ATo0w7pVLNbtTaBBFBlGVQRpw8DpkVtFvLBMWzmTqzRpSGB6WDfvtzKvQWqRjnaX541xR9l8UizjwG_C9svvrLFB5uJjE8e7HHroP673hRV_1zwb_9uAzXakS0H7AavHwmP5EqFOYX-VS_g_pm_bT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomal+LncRNAs+and+hepatocellular+Carcinoma%3A+From+basic+research+to+clinical+practice&rft.jtitle=Biochemical+pharmacology&rft.au=Li%2C+Liangyun&rft.au=Bi%2C+Yihui&rft.au=Diao%2C+Shaoxi&rft.au=Li%2C+Xiaofeng&rft.date=2022-06-01&rft.pub=Elsevier+Inc&rft.issn=0006-2952&rft.volume=200&rft_id=info:doi/10.1016%2Fj.bcp.2022.115032&rft.externalDocID=S0006295222001265
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2952&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2952&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2952&client=summon